Skip to main navigation Skip to search Skip to main content

A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects with Secondary Progressive Multiple Sclerosis

Project: Research

Project Details

StatusFinished
Effective start/end date02/14/13 → 05/25/18

Funding

  • Opexa Therapeutics: $210,883.50